|
|
|
| Analysis of medical expenses in public hospitals in Shandong Province after the elimination of drug price addiction |
| ZHOU Yue1 MO Yingning2 |
1.School of Medicine, Shandong University of Traditional Chinese Medicine, Shandong Province, Ji′nan 250300, China;
2.School of Management, Shandong University of Traditional Chinese Medicine, Shandong Province, Ji′nan 250300, China |
|
|
|
Abstract Objective To analyze the changes in the medical expenses of public hospitals in Shandong Province after the elimination of drug price addiction, and to provide reference suggestions for optimizing the structure of medical expenses and ensuring the public welfare and sustainable development of public hospitals. Methods Statistical analysis was made on the medical expenses of public hospitals from 2010 to 2018, and the number of public hospitals included in the tertiary, secondary, primary and unrated public hospitals in Shandong Province was 155, 335, 210, and 109, respectively. Results From 2010 to 2018, the average outpatient expenses increased from 167.3 yuan to 257.9 yuan, with an average annual growth rate of 6.8%. The per capita hospitalization expenses increased from 6415.9 yuan to 9845.7 yuan, with an average annual growth rate of 6.7%. The proportion of drugs decreased, but the proportion of outpatient drugs was still higher than 30%. All levels of hospitals accounted for the highest proportion of drug costs, and the primary hospitals accounted for the highest proportion of drug costs. Conclusion It is of positive significance to cancel drug price addiction, but the government investment must be timely and sink， otherwise the excessive compensation mechanism will increase the burden on patients. At the same time, strengthen the standardized operation of the pharmaceutical market, reduce the cost of medicines and health materials, and deepen the policy of tiered diagnosis and treatment.
|
|
|
|
|
|
[1] 赵静.基于公立医院改革的军队医院费用补偿机制研究[D].上海：第二军医大学，2017.
[2] 王孔亮.取消药品加成对公立医院的影响及对策研究[D].青岛：青岛大学，2018.
[3] 张睿.新医改背景下县级公立医院财政补偿绩效评价研究[D].南京：东南大学，2016.
[4] 毛颖欢，李琼.取消药品加成与医疗服务价格调整的影响[J].中国卫生标准管理，2019，10（18）：25-28.
[5] 郭晶.A医院国际医疗部发展战略研究[D].北京：对外经济贸易大学，2016.
[6] 刘笑，方鹏骞.医疗费用控制背景下公立医院医疗质量保障对策分析[J].中国医院管理，2019，39（11）：26-28.
[7] 陆正洪.基于SWOT分析的公立医院药事服务费政策研究[J].中国卫生事业管理，2017，34（8）：597-599，625.
[8] 闻庆柱，刘倩，高文凤，等.取消药品加成公立医院收支状况及医疗费用变化分析[J].中国医院管理，2018，38（8）：4-7.
[9] 马海燕.宁夏某地城市公立医院取消药品加成后运营效果分析及其实际补偿率测算[D].银川：宁夏医科大学，2019.
[10] 马丽文，宫春博.山东省公立医院医疗费用控制效果分析[J].中国医药导报，2019，16（25）：171-174，188.
[11] 张远妮.公共政策视角下医疗服务价格改革政策效果及风险评估研究[D].广州：南方医科大学，2019.
[12] 李佳琳.我国公立医院管理体制改革研究[D].济南：山东大学，2016.
[13] 孔香云.取消药品加成政策对省级公立医院运营的影响及对策分析[D].济南：山东大学，2017.
[14] 董盼盼，窦蕾，屈晓远，等.公立医院补偿机制改革宏观影响因素的政策情景分析[J].中国医院管理，2018，38（1）：11-13.
[15] 魏铭.我国药品定价制度分析和国外经验启示[J].经济师，2018（7）：44-45.
[16] 李伟.公立医院改革研究综述[J].经济研究参考，2016（24）：41-53.
[17] 韩志琰，温楠，宋奎勐，等.山东省公立医院患者医疗费用结构变动分析[J].卫生软科学，2018，32（2）：40-45.
[18] 谭礼萍.住院医疗费用构成的结构变动度分析[J].中国卫生统计，2015，32（3）：441-442，445.
[19] 孟楠，董良，王美霞，等.取消药品加成医疗服务价格调整政策对公立医院的影响——以山东省J医院为例[J].卫生软科学，2020，34（2）：9-13.
[20] 陈丽霏，吕凯结，肖林，等.取消药品加成对公立医院用药架构的影响研究[J].中国医药科学，2020，10（6）：197-199.
[21] 殷婷，汤少梁，杨泽华，等.后以药养医时代公立医院药房改革模式初探[J].中国医院管理，2019，39（1）：6-8. |
|
|
|
